Fairmount Funds Management LLC - Director, 10%+ Owner at Damora Therapeutics, Inc.

Issuer-level insider activity

Role: Director, 10%+ Owner
Issuer ticker: DMRA on Nasdaq
Entity type: Company
Source filing history: Open source filing history

No buys or sells have been reported by Fairmount Funds Management LLC since 28 Sep 2025

Reported holdings for Fairmount Funds Management LLC in Damora Therapeutics, Inc.

Form 4 holding Director, 10%+ Owner

Galecto, Inc.

Security class: Common Stock
Shares / value: 5,809,000
Estimated value: $126,752,380
Report date: 09 Feb 2026
Price: $21.82
Ownership: By Fairmount Healthcare Fund II L.P.

Form 4 holding Director, 10%+ Owner

Galecto, Inc.

Security class: Common Stock
Shares / value: 2,904,000
Estimated value: $63,365,280
Report date: 09 Feb 2026
Price: $21.82
Ownership: By Fairmount Healthcare Co-Invest V L.P.

Form 4 holding Director, 10%+ Owner

Damora Therapeutics, Inc.

Security class: Stock Option (right to buy)
Shares / value: 37,313
Estimated value
Report date: 23 Mar 2026
Price
Ownership: By: Peter Harwin
Underlying class: Common Stock
Underlying amount

Form 4 holding Director, 10%+ Owner

Damora Therapeutics, Inc.

Security class: Stock Option (right to buy)
Shares / value: 37,313
Estimated value
Report date: 23 Mar 2026
Price
Ownership: By: Peter Harwin
Underlying class: Common Stock
Underlying amount

Form 4 holding 10%+ Owner

Damora Therapeutics, Inc.

Security class: Stock Option (right to buy)
Shares / value: 37,313
Estimated value
Report date: 23 Mar 2026
Price
Ownership: By: Peter Harwin
Underlying class: Common Stock
Underlying amount

Form 4 holding Director, 10%+ Owner

Damora Therapeutics, Inc.

Security class: Stock Option (right to buy)
Shares / value: 37,313
Estimated value
Report date: 23 Mar 2026
Price
Ownership: By: Peter Harwin
Underlying class: Common Stock
Underlying amount

Form 4 holding Director, 10%+ Owner

Damora Therapeutics, Inc.

Security class: Stock Option (right to buy)
Shares / value: 37,313
Estimated value
Report date: 23 Mar 2026
Price
Ownership: By: Peter Harwin
Underlying class: Common Stock
Underlying amount

Form 4 holding Director, 10%+ Owner

Galecto, Inc.

Security class: Series C Preferred Stock
Shares / value: 1,148
Estimated value
Report date: 09 Feb 2026
Price
Ownership: By Fairmount Healthcare Fund II L.P.
Underlying class: Common Stock
Underlying amount

Form 4 holding Director, 10%+ Owner

Galecto, Inc.

Security class: Series C Preferred Stock
Shares / value: 574
Estimated value
Report date: 09 Feb 2026
Price
Ownership: By Fairmount Healthcare Co-Invest V L.P.
Underlying class: Common Stock
Underlying amount

Transaction history for Fairmount Funds Management LLC in Damora Therapeutics, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .